Robert Cascella

Robert Cascella (senior executive) discloses dealings in 4 companies, chiefly KORU Medical Systems, Inc., Neuronetics, Inc. and Mirion Technologies, Inc. We count 48 filings; the first trade dates from 27 May 2021 and the latest from 1 October 2026.

The open-market record is one-sided, with 8 purchases worth €453k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 37 share grants and 2 option exercises.

In size, the median ticket on the buying side is €51k. Of 7 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 6 purchases with a full 90-day history, the hit rate stands at 17% and the median 90-day move at -13.5%. These figures describe past trades and do not predict future prices.

The record was last updated on 1 October 2026 with an option exercise in Celestica Inc. The last insider purchase was made public on 13 September 2024, 765 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.